Stay updated on TAR-200 Combo & Cetrelimab in Bladder Cancer Clinical Trial
Sign up to get notified when there's something new on the TAR-200 Combo & Cetrelimab in Bladder Cancer Clinical Trial page.

Latest updates to the TAR-200 Combo & Cetrelimab in Bladder Cancer Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe footer revision tag was updated from v3.6.6 to v3.7.0, signaling a platform software update to the history view. It does not modify the recorded study data or history entries.SummaryDifference0.1%

- Check36 days agoChange DetectedThe page's revision indicator was updated from v3.6.5 to v3.6.6, reflecting an administrative refresh of the record history. This is a metadata change rather than a substantive update to the study information.SummaryDifference0.1%

- Check57 days agoChange DetectedRevision label in the record history changed from v3.6.4 to v3.6.5, indicating a new revision entry was added. This change affects only the metadata shown in the history and does not alter the study data or results.SummaryDifference0.0%

- Check72 days agoChange DetectedThe page history now includes a new Revision: v3.6.4 entry. The previous Revision: v3.6.3 has been removed, updating the page's revision metadata.SummaryDifference0.0%

- Check93 days agoChange DetectedA new Revision: v3.6.3 entry has been added to the history and the previous Revision: v3.6.2 entry has been removed, representing an updated software version tag in the record history.SummaryDifference0.0%

- Check100 days agoChange DetectedThe record update shows the study has completed and has a refreshed revision, replacing the previous Active, not recruiting status as part of the update.SummaryDifference0.4%

Stay in the know with updates to TAR-200 Combo & Cetrelimab in Bladder Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the TAR-200 Combo & Cetrelimab in Bladder Cancer Clinical Trial page.